Mesoblast, Limited


Mesoblast is a world leader in developing innovative cellular medicines.

We have established what we believe is the industry’s most clinically advanced and diverse portfolio of cell-based products with five programs in active Phase 3 clinical studies or Phase 3-ready, and four programs in Phase 2.

All our clinical programs target significant, under-served therapeutic areas including cardiac diseases, spine orthopedic disorders, oncology and hematology diseases, and immune-mediated and inflammatory conditions.


55 Collins Street , Level 39
Corporate Headquarters
Melbourne 3000

Get Directions

Upgrade Your Listing